The government has approved a fund of 3,625 million baht for two Thai vaccine projects against COVID-19, ChulaCov19 mRNA...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Q2 Solutions, a wholly owned subsidiary of ...
US-based Novavax, Inc. and Serum Institute of India have announced that the National Agency of Drug and Food Contro...
There is a common pearl of Indian wisdom that encourages parents to let their children play outside in the sun, rain, ga...
Taiwan's Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an indep...
Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...
There’s been a significant breakthrough in the development of a vaccine to prevent hookworm infection, a parasite ...
The Health Sciences Authority (HSA) in Singapore has granted an interim authorisation under the Pandemic Special Access ...
1. Who Is Eligible for a COVID Booster Shot? As of now, the U.S. Centers for Disease Control and Prevention (CD...
Taiwan-based Medigen Vaccine Biologics Corporation has recently stated that MVC-COV1901, a recombinant protein vacc...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Cent...
Norway-based Coalition for Epidemic Preparedness Innovations, or CEPI, has launched a new call for proposals to fund cli...
American firm Moderna, Inc. will build a state-of-the-art mRNA facility in Africa with the goal of producing u...
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine (Mosquirix)...
To boost Singapore’s biopharmaceutical sector, Australia-based Lendlease is commencing construction of a large-sca...
The International Vaccine Institute (IVI) in South Korea, the Texas Children’s Hospital Center for Vaccine Develop...
Jiangsu Recbio Technology and Shenzhen Rhegen Biotechnology have recently signed a joint venture agreement to establish ...
Indian vaccine manufacturer Serum Institute of India (SII) and its US-based partner Novavax, have announced a regulatory...
